首页 | 期刊导航 | 学习空间 | 退出

期刊文章列表

  • Shi Wang1,Yining Song2,Jingge Ma1,Xinyang Chen1,Yuanhui Guan1,Hui Peng1,Guoqing Yan1,Rupei Tang1(Engineering Research Center for Biomedical Materials,Anhui Key Laboratory of Modern Biomanufacturing,School of Life Sciences,Anhui University;Anhui Engineering Technology Research Center of Biochemical Pharmaceutical,Bengbu Medical College).Dynamic crosslinked polymeric nano-prodrugs for highly selective synergistic chemotherapy[J].Asian Journal of Pharmaceutical Sciences,2022,第6期
  • Huijuan Zhang1,2,3,Yaping Wang1,Mengting Li1,Kexuan Cao1,Zijun Qi1,Ling Zhu1,2,3,Zhenzhong Zhang1,2,3,Lin Hou1,2,3(School of Pharmaceutical Sciences,Zhengzhou University;Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases;Collaborative Innovation Center of New Drug Research and Safety Evaluation).A self-guidance biological hybrid drug delivery system driven by anaerobes to inhibit the proliferation and metastasis of colon cancer[J].Asian Journal of Pharmaceutical Sciences,2022,第6期
  • Qianwen Shao1,Tianhao Ding1,Feng Pan1,Guanghui Li,Shun Shen3,Jun Qian1,Changyou Zhan1,3,Xiaoli Wei1(School of Pharmacy & Department of Pharmacology,School of Basic Medical Sciences,Fudan University;Department of Pharmacy,Jing’an District Central Hospital of Shanghai;Department of Pharmacy & Center for Medical Research and Innovation,Shanghai Pudong Hospital,Fudan University Pudong Medical Center).Protein corona mediated liposomal drug delivery for bacterial infection management[J].Asian Journal of Pharmaceutical Sciences,2022,第6期
  • Linping Jiang,Kesi Wang,Liyan Qiu(Ministry of Educational (MOE) Key Laboratory of Macromolecular Synthesis and Functionalization,Department of Polymer Science and Engineering,Zhejiang University).Doxorubicin hydrochloride and L-arginine co-loaded nanovesicle for drug resistance reversal stimulated by near-infrared light[J].Asian Journal of Pharmaceutical Sciences,2022,第6期
  • Jingyi Hu1,Qiong Bian1,2,Xiaolu Ma1,Yihua Xu1,Jianqing Gao1,3(Institute of Pharmaceutics,College of Pharmaceutical Sciences,Zhejiang University;College of Pharmacy,Inner Mongolia Medical University;Jiangsu Engineering Research Center for New-type External and Transdermal Preparations).A double-edged sword:ROS related therapies in the treatment of psoriasis[J].Asian Journal of Pharmaceutical Sciences,2022,第6期
  • Yonglong He1,Wanting Zhang1,Qingqing Xiao1,Lifang Fan2,Dechun Huang3,Wei Chen3,Wei He4,1(School of Pharmacy,China Pharmaceutical University;Jiangsu Aosaikang Pharmaceutical Co.,Ltd.;School of Engineering,China Pharmaceutical University;Shanghai Skin Disease Hospital,Tongji University School of Medicine).Liposomes and liposome-like nanoparticles:From anti-fungal infection to the COVID-19 pandemic treatment[J].Asian Journal of Pharmaceutical Sciences,2022,第6期
  • Na Yin1,Wenjun Zhang1,Runxiu Wei1,Qiang Yang1,Fengming He2,Ling Guo1,3,Min Feng1(School of Pharmaceutical Sciences,Sun Yat-Sen University;School of Pharmaceutical Sciences,Xiamen University;School of Pharmaceutical Sciences,Hainan University).Liposome cocktail activator modulates hepatocytes and remodels the microenvironment to mitigate acute liver failure[J].Asian Journal of Pharmaceutical Sciences,2022,第6期
  • Yanjuan Huang,Tao Zhang,Qin Wei,Zishan Zeng,Yujun Gong,Xiaoyu Xu,Meixu Chen,Chunshun Zhao(School of Pharmaceutical Sciences,Sun Yat-sen University).“NIR-triggered ROS storage” photodynamic intraocular implant for high-efficient and safe posterior capsular opacification prevention[J].Asian Journal of Pharmaceutical Sciences,2022,第6期
  • Tao Wang1,Yunran Zhang1,2,Meiling Chi1,Chen Zhao1,Linlin Cao3,Chutong Tian1,K.Kamei1,Ying Zheng4,Qikun Jiang1(Department of Pharmaceutics,Wuya College of Innovation,Shenyang Pharmaceutical University;Changzhou pharmaceutical factory co.LTD;Department of Pharmaceutics,The Second Hospital of Dalian Medical University;State Key Laboratory of Quality Research in Chinese Medicine,Institute of Chinese Medical Sciences,University of Macau).A novel fixed-combination timolol-netarsudillatanoprost ophthalmic solution for the treatment of glaucoma and ocular hypertension[J].Asian Journal of Pharmaceutical Sciences,2022,第6期
  • Shilin Jin1,2,Zhongyue Lv1,2,Lin Kang1,2,Jiayi Wang1,2,Chengcheng Tan1,2,Liming Shen1,2,Liang Wang1,2,Jing Liu1,2(Stem Cell Clinical Research Center,National Joint Engineering Laboratory,The First Affiliated Hospital of Dalian Medical University;Liaoning Key Laboratory of Frontier Technology of Stem Cell and Precision Medicine,Dalian Engineering Research Center for GeneticVariation Detection of Infectious Pathogenic Microorganisms,Dalian Innovation Institute of Stem Cell and Precision Medicine).Next generation of neurological therapeutics:Native and bioengineered extracellular vesicles derived from stem cells[J].Asian Journal of Pharmaceutical Sciences,2022,第6期
  • Gaofeng Shu1,2,Lin Shen1,Jiayi Ding1,Junchao Yu1,Xiaoxiao Chen2,Xiaoju Guo3,Enqi Qiao2,Yaning Chen2,Chenying Lu1,2,Zhongwei Zhao1,2,Yongzhong Du4,Minjiang Chen1,2,4,Jiansong Ji1,2(Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention Research,Institute of Imaging Diagnosis and Minimally Invasive Intervention Research,The Fifth Affiliated Hospital of Wenzhou Medical University;Department of radiology,Lishui Hospital of Zhejiang University,School of Medicine;Shaoxing University School of Medcine;Institute of Pharmaceutics,College of Pharmaceutical Sciences,Zhejiang University).Fucoidan-based dual-targeting mesoporous polydopamine for enhanced MRI-guided chemo-photothermal therapy of HCC via P-selectin-mediated drug delivery[J].Asian Journal of Pharmaceutical Sciences,2022,第6期
  • Ziting Zhang1,You Ji2,Nan Hu,Qinqi Yu1,Xinrui Zhang1,Jie Li1,Fenglei Wu,Huae Xu2,Qiyun Tang1,Xiaolin Li1(Department of Geriatric Gastroenterology,the First Affiliated Hospital of Nanjing Medical University;Department of Pharmaceutics,School of Pharmacy,Nanjing Medical University;Department of Oncology,the Affiliated Hospital of Kangda College of Nanjing Medical University & the First People’s Hospital of Lianyungang).Ferroptosis-induced anticancer effect of resveratrol with a biomimetic nano-delivery system in colorectal cancer treatment[J].Asian Journal of Pharmaceutical Sciences,2022,第5期
  • Lingmin Zhang1,Langyu Yang1,Jionghua Huang1,Sheng Chen2,Chuangjia Huang1,Yinshan Lin1,Ao Shen1,Zhou Yikang Zheng2,Wenfu Zheng3,Shunqing Tang2(Key Laboratory of Molecular Target & Clinical Pharmacology and the State & NMPA Key Laboratory of Respiratory Disease,School of Pharmaceutical Sciences & The Third and Fifth Affiliated Hospital,Guangzhou Medical University;Department of Biomedical Engineering,Jinan University;CAS Key Lab for Biological Effects of Nanomaterials and Nanosafety,National Center for Nano Science and Technology).A zwitterionic polymer-inspired material mediated efficient CRISPR-Cas9 gene editing[J].Asian Journal of Pharmaceutical Sciences,2022,第5期
  • Yarong Zhao,Yang Yu,Simiao Wang,Jiaxin Li,Lesheng Teng(School of Life Sciences,Jilin University).Small extracellular vesicles encapsulating lefty1 mRNA inhibit hepatic fibrosis[J].Asian Journal of Pharmaceutical Sciences,2022,第5期
  • Xudong Fan1,Tianxiang Yue1,Aidi Liu1,Xiaowei Xie1,Weixiang Fang1,Yinghui Wei1,Hangsheng Zheng1,Hongyue Zheng2,Meiqi Zhou3,Jigang Piao1,4,5,Fanzhu Li1,4(School of Pharmaceutical Sciences,Zhejiang Chinese Medical University;Libraries of Zhejiang Chinese Medical University,Zhejiang Chinese Medical University;Department of Breast Surgery,Key Laboratory of Cancer Prevention and Intervention,China National Ministry of Education,Second Hospital of Zhejiang,University College of Medicine;Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province,School of Pharmaceutical Sciences,Zhejiang Chinese Medical University;Academy of Chinese Medical Sciences,Zhejiang Chinese Medical University).Lignin-assisted construction of sub-10 nm supramolecular self-assembly for photothermal immunotherapy and potentiating anti-PD-1 therapy against primary and distant breast tumors[J].Asian Journal of Pharmaceutical Sciences,2022,第5期
  • Yanjuan Huang1,Hualu Lai2,Jingwen Jiang1,Xiaoyu Xu1,Zishan Zeng1,Lingling Ren1,Qiuxing Liu2,Meixu Chen1,Tao Zhang1,Xin Ding2,Chunshun Zhao1,Shengmiao Cui2,3(School of Pharmaceutical Sciences,Sun Yat-sen University;School of Traditional Chinese Medicine,Guangdong Pharmaceutical University;Guangdong Provincial Key Laboratory of Advanced Drug Delivery Systems,Guangdong Pharmaceutical University).pH-activatable oxidative stress amplifying dissolving microneedles for combined chemo-photodynamic therapy of melanoma[J].Asian Journal of Pharmaceutical Sciences,2022,第5期
  • Ruinan Wu,Zhanghan Wu,Liyun Xing,Xi Liu,Lei Wu,Zhou Zhou,Lian Li,Yuan Huang(Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province,Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology,West China School of Pharmacy,Sichuan University).Mimicking natural cholesterol assimilation to elevate the oral delivery of liraglutide for type Ⅱ diabetes therapy[J].Asian Journal of Pharmaceutical Sciences,2022,第5期
  • Guangshuai Zhang1,Haishan Guan1,Jianfeng Li1,Mo Li2,Xiaofan Sui2,Baocheng Tian3,Huiming Dong4,Bingyang Liu1,Zhonggui He1,Ning Li5,Mingming Zhao6,Qiang Fu1(Wuya College of Innovation,Shenyang Pharmaceutical University;Liaoning Institute for Drug Control;School of Pharmacy,Binzhou Medical University;Liaoning Inspection Examination and Certification Centre;School of Pharmacy,Shenyang Pharmaceutical University;Department of Pharmacy,Shengjing Hospital of China Medical University).Roles of effective stabilizers in improving oral bioavailability of naringenin nanocrystals:Maintenance of supersaturation generated upon dissolution by inhibition of drug dimerization[J].Asian Journal of Pharmaceutical Sciences,2022,第5期
  • Hyemin Ju,Dongyoon Kim,Yu-Kyoung Oh(College of Pharmacy and Research Institute of Pharmaceutical Sciences,Seoul National University).Lipid nanoparticle-mediated CRISPR/Cas9 gene editing and metabolic engineering for anticancer immunotherapy[J].Asian Journal of Pharmaceutical Sciences,2022,第5期
  • Canyu Yang1,Shumin Fan2,Xing Wang1,Wei Liu3,Long Yang2,Bing He2,4,Wenbing Dai2,Hua Zhang2,Xueqing Wang1,2,Qiang Zhang1,2,4(Department of Pharmacy Administration and Clinical Pharmacy,School of Pharmaceutical Science,Peking University;Beijing Key Laboratory of Molecular Pharmaceutics,New Drug Delivery Systems,School of Pharmaceutical Sciences,Peking University;Department of Pharmacy,Peking University Third Hospital;State Key Laboratory of Natural and Biomimetic Drugs,Peking University).Optimize the combination regimen of Trastuzumab and Nab-paclitaxel in HER2-positive tumors via modulating Caveolin-1 expression by lovastatin[J].Asian Journal of Pharmaceutical Sciences,2022,第5期
  • Quanyi Jin1,Wenbao Zuo1,Qian Lin1,Ting Wu2,Cong Liu2,Nian Liu1,Jinxue Liu1,Xuan Zhu1(Fujian Provincial Key Laboratory of Innovative Drug Target Research,School of Pharmaceutical Sciences,Xiamen University;Cancer Research Center,School of Medicine,Xiamen University).Zinc-doped Prussian blue nanoparticles for mutp53-carrying tumor ion interference and photothermal therapy[J].Asian Journal of Pharmaceutical Sciences,2022,第5期
  • Chu Qiao,Haiying Wang,Qiutong Guan,Minjie Wei,Zhenhua Li(School of Pharmacy,China Medical University).Ferroptosis-based nano delivery systems targeted therapy for colorectal cancer:Insights and future perspectives[J].Asian Journal of Pharmaceutical Sciences,2022,第5期
  • Yuying Zhao1,Ning Liu2,3,Piaoxue Liu1,Taojian Fan2,3,Rui Ma1,Huijie Hong4,Xiaojia Chen4,Zhongjian Xie5,6,Han Zhang2,Qi Wang1,Tongkai Chen1(Science and Technology Innovation Center,Guangzhou University of Chinese Medicine;Institute of Microscale Optoelectronics,Collaborative Innovation Centre for Optoelectronic Science & Technology,Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province,College of Physics and Optoelectronic Engineering,Shenzhen Key Laboratory of Micro-Nano Photonic Information Technology,Guangdong Laboratory of Artificial Intelligence and Digital Economy (SZ),Shenzhen University;College of Health Science and Environmental Engineering,School of Shenzhen Technology University;State Key Laboratory of Quality Research in Chinese Medicine,Institute of Chinese Medical Sciences,University of Macau;Institute of Pediatrics,Shenzhen Children's Hospital;Shenzhen International Institute for Biomedical Research).Robust boron nanoplatform provokes potent tumoricidal activities via inhibiting heat shock protein[J].Asian Journal of Pharmaceutical Sciences,2022,第5期
  • Mia Karam1,2,Georges Daoud3(Biomedical Engineering Program,Maroun Semaan Faculty of Engineering and Architecture;Department of Biochemistry and Molecular Genetics,Faculty of Medicine;Department of Anatomy,Cell Biology,and Physiological Sciences,Faculty of Medicine,American University of Beirut).mRNA vaccines:Past,present,future[J].Asian Journal of Pharmaceutical Sciences,2022,第4期
  • Shengmei Wang1,2,Xuanjun Liu1,3,Minghua Yang4,Linqi Ouyang2,Jinsong Ding3,Shengfeng Wang1,3,4,Wenhu Zhou1,3(Department of Pharmacy,The Third Xiangya Hospital,Central South University;Xiangya School of Pharmaceutical Sciences,Central South University;Postdoctoral Research Station of Clinical Medicine and Department of Pediatrics,The Third Xiangya Hospital,Central South University;The First Hospital of Hunan University of Chinese Medicine).Non-cytotoxic nanoparticles re-educating macrophages achieving both innate and adaptive immune responses for tumor therapy[J].Asian Journal of Pharmaceutical Sciences,2022,第4期
  • Qiongzhe Ren1,Xuefeng Tang2,Yi Lu3,Qing Li1,Zhiqian Liao1,Shinan Jiang1,Haoli Zhang4,Zhigang Xu3,Lei Luo1(College of Pharmaceutical Sciences,Southwest University;Department of Pathology,Chongqing General Hospital,University of Chinese Academy of Sciences;School of Materials and Energy and Chongqing Engineering Research Center for Micro–Nano Biomedical Materials and Devices,Southwest University;State Key Laboratory of Applied Organic Chemistry(SKLAOC),College of Chemistry and Chemical Engineering,Key Laboratory of Special Function Materials and Structure Design(MOE),Lanzhou University).Design,preparation and pharmacodynamics of ICG-Fe(Ⅲ)based HCPT nanocrystals against cancer[J].Asian Journal of Pharmaceutical Sciences,2022,第4期
  • ka hong wong,donglin yang,shanshan chen,chengwei he,meiwan chen(State Key Laboratory of Quality Research in Chinese Medicine,Institute of Chinese Medical Sciences,University of Macau).Development of nanoscale drug delivery systems of dihydroartemisinin for cancer therapy:A review[J].Asian Journal of Pharmaceutical Sciences,2022,第4期
  • Yingke Liu1,Zhihe Zhao1,Man Li2(State Key Laboratory of Oral Diseases,National Clinical Research Center for Oral Diseases,West China Hospital of Stomatology,Sichuan University;Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province,Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology,West China School of Pharmacy,Sichuan University).Overcoming the cellular barriers and beyond:Recent progress on cell penetrating peptide modified nanomedicine in combating physiological and pathological barriers[J].Asian Journal of Pharmaceutical Sciences,2022,第4期
  • Si Dong1,2,Sheng Ma2,3,Hongyu Chen2,4,Zhaohui Tang2,4,3,Wantong Song2,3,Mingxiao Deng1(College of Chemistry,Northeast Normal University;Key Laboratory of Polymer Ecomaterials,Changchun Institute of Applied Chemistry,Chinese Academy of Sciences;University of Science and Technology of China;Jilin Biomedical Polymers Engineering Laboratory).Nucleobase-crosslinked poly(2-oxazoline)nanoparticles as paclitaxel carriers with enhanced stability and ultra-high drug loading capacity for breast cancer therapy[J].Asian Journal of Pharmaceutical Sciences,2022,第4期
  • Yuri Svirkin1,Jaeweon Lee1,Richard Marx1,Seongkyu Yoon2,Nelson Landrau1,Md Abul Kaisar3,Bin Qin3,Jin H. Park3,Khondoker Alam3,Darby Kozak3,Yan Wang3,Xiaoming Xu4,Jiwen Zheng5,Benjamin Rivnay1(Landrau Scientific Innovations,Leominster,MA,United States of America;University of Massachusetts Lowell,Lowell,MA,United States of America;Office of Research and Standards,Office of Generic Drugs,Center for Drug Evaluation and Research,U.S.Food and Drug Administration,Silver Spring,MD,United States of America;Office of Testing and Research,Office of Pharmaceutical Quality,Center for Drug Evaluation and Research,U.S.Food and Drug Administration,Silver Spring,MD,United States of America;Office of Science and Engineering Laboratories,Center for Devices and Radiological Health,U.S.Food and Drug Administration,Silver Spring,MD,United States of America).Amphotericin B release rate is the link between drug status in the liposomal bilayer and toxicity[J].Asian Journal of Pharmaceutical Sciences,2022,第4期
首页 1 2 3 下一页 尾页 共有3页,转到 页

帮助 | 繁體中文 | 关于发现 | 联系我们

超星发现系统 Copyright©·powered by 超星

客服电话:4008236966